Top Story

A look back at CONVERGE, on today’s MedHeads

A lot of bases in healthcare innovation were covered at CONVERGE this week. We’ll reflect back on some highlights.

It was an exciting week for MedCity News.

We held our annual CONVERGE event in Philadelphia, and a lot of bases were covered when it comes to innovation in healthcare.

For this week’s MedHeads, Stephanie Baum, Neil Versel and I will reflect back on some of the surprises and interesting insights from panels and startups at the conference that stood out to us.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

We’ll touch on topics such as the controversial precision medicine debate and Kathleen Goetz’s keynote highlighting what’s next for IBM Watson. We’ll also talk about a couple of the startups that appeared in our CONVERGE NOW interviews, like Conceivable and Windgap Medical.

MedHeads, as it does every Friday, starts at 4 pm Eastern today. Join us live via the YouTube embed below or on our Google Hangout On Air page.

[youtube http://www.youtube.com/watch?v=JqvOy5HZEu0]